 |
|
The Association between Choroidal Thickness Variations and Response to Intravitreal Bevacizumab in Central Serous Chorioretinopathy
Dong Yoon Kim, Soo Geun Joe, Sung Jae Yang, Joo Yong Lee, June-Gone Kim, Young Hee Yoon
Korean J Ophthalmol. 2015;29(3):160-167. Published online 2015 May 20 DOI: https://doi.org/10.3341/kjo.2015.29.3.160
|
|
Citations to this article as recorded by
 Central serous chorioretinopathy: An evidence-based treatment guideline
Helena M.A. Feenstra, Elon H.C. van Dijk, Chui Ming Gemmy Cheung, Kyoko Ohno-Matsui, Timothy Y.Y. Lai, Hideki Koizumi, Michael Larsen, Giuseppe Querques, Susan M. Downes, Suzanne Yzer, Mark P. Breazzano, Yousif Subhi, Ramin Tadayoni, Siegfried G. Prigling
Progress in Retinal and Eye Research.2024; : 101236. CrossRef Effect of Focal Laser Photocoagulation on the Ganglion Cell Complex Thickness in Acute Central Serous Chorioretinopathy
A Young Lee, Jinyoung Choi, Sang Un Lee, Chul Woo Kim, Daniel Duck-Jin Hwang
Journal of Clinical Medicine.2024; 13(4): 1064. CrossRef Relationship between ganglion cell complex thickness and vision in age-related macular degeneration treated with aflibercept
Cihan Buyukavsar, Murat Sonmez, Sercan Koray Sagdic, Melih Hamdi Unal
European Journal of Ophthalmology.2023; 33(4): 1672. CrossRef Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome
David Xu, Elisha Garg, Kook Lee, Yoichi Sakurada, Atchara Amphornphruet, Nopasak Phasukkijwatana, Sandra Liakopoulos, Scott Eugene Pautler, Allan E Kreiger, Suzanne Yzer, Won Ki Lee, SriniVas Sadda, K Bailey Freund, David Sarraf
British Journal of Ophthalmology.2022; 106(4): 576. CrossRef Central serous chorioretinopathy: Treatment
JongBeom Park, Kiyoung Kim, MinSeok Kang, EungSuk Kim, Seung-Young Yu
Taiwan Journal of Ophthalmology.2022; 12(4): 394. CrossRef Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy
Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh, Sung Chul Lee, Demetrios G. Vavvas
PLOS ONE.2020; 15(9): e0238725. CrossRef Central serous chorioretinopathy: Towards an evidence-based treatment guideline
Thomas J. van Rijssen, Elon H.C. van Dijk, Suzanne Yzer, Kyoko Ohno-Matsui, Jan E.E. Keunen, Reinier O. Schlingemann, Sobha Sivaprasad, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Felice Cardillo Piccolino, Jay K. Chhablani, Timothy
Progress in Retinal and Eye Research.2019; 73: 100770. CrossRef Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis
Shangli Ji, Yemei Wei, Jiansu Chen, Shibo Tang
International Journal of Clinical Pharmacy.2017; 39(3): 514. CrossRef Intravitreal Aflibercept for the Treatment of Subacute Central Serous Chorioretinopathy
Young Hee Yoon, Dong Yoon Kim, Young-Ju Lew, Kyu-Hyung Park, Ju Byung Chae, Joo Yong Lee, Soo Geun Joe, Sung Jae Yang, Sang Jin Kim
Journal of VitreoRetinal Diseases.2017; 1(2): 101. CrossRef CHANGE OF CHOROIDAL VOLUME IN UNTREATED CENTRAL SEROUS CHORIORETINOPATHY
Laura Pertl, Anton Haas, Silke Hausberger, Tamara Pichler, Dieter F. Rabensteiner, Gerald Seidel, Eva M. Malle, Martin Weger
Retina.2017; 37(9): 1792. CrossRef Leitlinien für die Betreuung und Behandlung von Patienten mit Chorioretinopathia centralis serosa
Michael Stur, Siamak Ansari-Shahrezaei, Anton Haas, Michael Tittl
Spektrum der Augenheilkunde.2016; 30(1): 39. CrossRef
|